Porsolt expanding in USA, starts building new lab in Canada

Announcing global expansion plans, Porsolt, a French contract research organization specializing in patho-physiological procedures, said it is  plans new manufacturing and increased US operations.

The firm has commenced construction of a new laboratory on a 10-hectare  development in Laval, Canada. The first phase of the operation will see  a 60,000 square foot facility completed in early 2010.

The new site will offer increased capacity for Porsolt's expanding  cross-therapeutic area models and Good Laboratory Practices safety  pharmacology expertise. Chief executive Mark Duxon said: "continued  growth in 2008, together with an increasing awareness in the  pharmaceutical industry of Porsolt's cross-therapeutic area expertise,  requires Porsolt to be placed for sustained growth in the next 5-10  years. Our acquisition of a 10 hectare plot of land in close proximity  to the existing laboratories will provide us a sustainable platform on  which to grow in line with the demands of our clients."